HOLX logo

Hologic (HOLX) Stock

Profile

Full Name:

Hologic, Inc.

Sector:

Healthcare

Country:

United States

IPO:

01 March 1990

Indexes:

Description:

Hologic, Inc. develops, manufactures, and supplies diagnostic products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company conducts molecular diagnostic tests Aptima to detect infectious microorganisms; quantitative viral load tests Aptima for HIV, hepatitis C, and hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 tests for detecting SARS-CoV-2; ThinPrep system for cytology use; a rapid fetal fibronectin test to help doctors assess the risk of premature birth; diagnostic tests for detecting group B streptococcus. The company also offers breast imaging and analysis services. Hologic, Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts.

Key Details

Price

$71.56

Annual Revenue

$4.03 B(0.00% YoY)

Annual EPS

$3.32(+81.42% YoY)

PE Ratio

21.49(-37.05% YoY)

Beta

0.13

Events Calendar

Earnings

Next earnings date:

Feb 05, 2025

Recent quarterly earnings:

Nov 04, 2024

Recent annual earnings:

Nov 04, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Apr 03, 2008

Analyst ratings

Recent major analysts updates

03 Feb '25 Needham
Hold
13 Jan '25 Needham
Buy
13 Jan '25 Morgan Stanley
Equal-Weight
19 Dec '24 Needham
Buy
13 Dec '24 Wolfe Research
Peer Perform
10 Dec '24 Jefferies
Hold
05 Nov '24 UBS
Neutral
05 Nov '24 Raymond James
Outperform
05 Nov '24 RBC Capital
Sector Perform
05 Nov '24 Mizuho
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Breast Health Performance Likely to Aid Hologic's Q1 Earnings
Breast Health Performance Likely to Aid Hologic's Q1 Earnings
Breast Health Performance Likely to Aid Hologic's Q1 Earnings
HOLX
zacks.com29 January 2025

In the first quarter of fiscal 2025, HOLX is anticipated to gain from the growth of its breast health products.

Hologic's Q1 Earnings Coming Up: How to Play the Stock?
Hologic's Q1 Earnings Coming Up: How to Play the Stock?
Hologic's Q1 Earnings Coming Up: How to Play the Stock?
HOLX
zacks.com28 January 2025

In the first quarter of fiscal 2025, HOLX is predicted to gain from the success of its main business areas.

Why Hologic (HOLX) Outpaced the Stock Market Today
Why Hologic (HOLX) Outpaced the Stock Market Today
Why Hologic (HOLX) Outpaced the Stock Market Today
HOLX
zacks.com22 January 2025

At the end of the last trading day, Hologic (HOLX) was priced at $71.19, which represents a 1.17% increase compared to the previous day.

Hologic: Reasonably, But Not Compellingly Valued
Hologic: Reasonably, But Not Compellingly Valued
Hologic: Reasonably, But Not Compellingly Valued
HOLX
seekingalpha.com17 January 2025

Hologic, Inc. has dropped about 20% from its recent peak, even though it reported strong quarterly results. The company is still growing both through its own efforts and by making several smaller acquisitions. Additionally, management has recently increased the amount of money allocated for stock buybacks. The following paragraphs will provide an updated analysis of Hologic, Inc.

Hologic Hits New 52-Week Low: How to Play the Stock Now?
Hologic Hits New 52-Week Low: How to Play the Stock Now?
Hologic Hits New 52-Week Low: How to Play the Stock Now?
HOLX
zacks.com15 January 2025

This week, HOLX reached its lowest point of the year, which shows how the market responded to its mixed results for the first quarter of fiscal 2025. However, the stock still has a good chance for recovery.

Hologic (HOLX) Stock Drops Despite Market Gains: Important Facts to Note
Hologic (HOLX) Stock Drops Despite Market Gains: Important Facts to Note
Hologic (HOLX) Stock Drops Despite Market Gains: Important Facts to Note
HOLX
zacks.com14 January 2025

At the end of the last trading day, Hologic (HOLX) was priced at $70.20, which represents a decrease of 0.13% compared to the previous day.

Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2025
Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2025
Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2025
HOLX
businesswire.com12 January 2025

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic has shared its initial revenue figures for the first quarter of fiscal year 2025.

Hologic (HOLX) Ascends But Remains Behind Market: Some Facts to Note
Hologic (HOLX) Ascends But Remains Behind Market: Some Facts to Note
Hologic (HOLX) Ascends But Remains Behind Market: Some Facts to Note
HOLX
Zacks09 January 2025

At the end of the last trading day, Hologic (HOLX) was priced at $72.73, which represents a slight increase of 0.05% compared to the day before.

Hologic (HOLX) Ascends But Remains Behind Market: Some Facts to Note
Hologic (HOLX) Ascends But Remains Behind Market: Some Facts to Note
Hologic (HOLX) Ascends But Remains Behind Market: Some Facts to Note
HOLX
zacks.com08 January 2025

At the end of the last trading day, Hologic (HOLX) was priced at $72.73, which represents a slight increase of 0.05% compared to the previous day.

HOLX Stock Gains Following the Acquisition of Gynesonics
HOLX Stock Gains Following the Acquisition of Gynesonics
HOLX Stock Gains Following the Acquisition of Gynesonics
HOLX
zacks.com07 January 2025

Hologic has finished buying Gynesonics, the company that created the Sonata System, for about $350 million.

FAQ

  • What is the primary business of Hologic?
  • What is the ticker symbol for Hologic?
  • Does Hologic pay dividends?
  • What sector is Hologic in?
  • What industry is Hologic in?
  • What country is Hologic based in?
  • When did Hologic go public?
  • Is Hologic in the S&P 500?
  • Is Hologic in the NASDAQ 100?
  • Is Hologic in the Dow Jones?
  • When was Hologic's last earnings report?
  • When does Hologic report earnings?
  • Should I buy Hologic stock now?

What is the primary business of Hologic?

Hologic, Inc. develops, manufactures, and supplies diagnostic products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company conducts molecular diagnostic tests Aptima to detect infectious microorganisms; quantitative viral load tests Aptima for HIV, hepatitis C, and hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 tests for detecting SARS-CoV-2; ThinPrep system for cytology use; a rapid fetal fibronectin test to help doctors assess the risk of premature birth; diagnostic tests for detecting group B streptococcus. The company also offers breast imaging and analysis services. Hologic, Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts.

What is the ticker symbol for Hologic?

The ticker symbol for Hologic is NASDAQ:HOLX

Does Hologic pay dividends?

No, Hologic does not pay dividends

What sector is Hologic in?

Hologic is in the Healthcare sector

What industry is Hologic in?

Hologic is in the Medical Instruments & Supplies industry

What country is Hologic based in?

Hologic is headquartered in United States

When did Hologic go public?

Hologic's initial public offering (IPO) was on 01 March 1990

Is Hologic in the S&P 500?

Yes, Hologic is included in the S&P 500 index

Is Hologic in the NASDAQ 100?

No, Hologic is not included in the NASDAQ 100 index

Is Hologic in the Dow Jones?

No, Hologic is not included in the Dow Jones index

When was Hologic's last earnings report?

Hologic's most recent earnings report was on 4 November 2024

When does Hologic report earnings?

The next expected earnings date for Hologic is 5 February 2025

Should I buy Hologic stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions